CBMG Cellular Biomedicine Group, Inc. gains 16% Sep 15, 2017

Cellular Biomedicine Group Inc., a biomedicine company, develops stem cell therapies for degenerative diseases and cancerous diseases in Greater China. It focuses on developing and marketing cell-based therapies to treat serious chronic and degenerative diseases, such as cancer, osteoarthritis, tissue damage, various inflammatory diseases, and metabolic diseases. The company develops treatments utilizing proprietary cell based technologies, including immune cell therapy for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint and autoimmune diseases; and tumor cell specific dendritic cell therapy. Cellular Biomedicine Group Inc. was incorporated in 2001 and is headquartered in Cupertino, California. http://www.priceseries.com/trade/CBMG-Cellular-Biomedicine-Group-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017082820170915.html